|
2025
|
P/S
|
Pharmaceutical preparations for the treatment or prevention
of heart failure. |
|
2024
|
Invention
|
Methods and compositions for the treatment of hepatic encephalopathy.
Methods of treating hepati... |
|
|
Invention
|
Sglt1 inhibitors for use in the treatment of hepatic encephalopathy. Methods of treating hepatic ... |
|
|
Invention
|
Methods of reducing the risk of cardiovascular events in patients with left ventricular hypertrop... |
|
|
Invention
|
Methods of treating type 1 diabetes and kidney disease.
Methods of using a sodium glucose cotran... |
|
|
Invention
|
Methods of treating type 1 diabetes and kidney disease. Methods of using a sodium glucose cotrans... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes; all of the foregoing excluding pharmac... |
|
|
Invention
|
Use of sotagliflozin for the treatment of patients with type 1 diabetes mellitus.
The invention ... |
|
2023
|
P/S
|
Printed matter, namely, brochures, magazines and leaflets all in the field of heart failure. Prov... |
|
|
P/S
|
Pharmaceutical preparations for the treatment or prevention of heart failure. |
|
|
P/S
|
Printed matter, namely, brochures, magazines and leaflets all in the field of heart failure Provi... |
|
|
Invention
|
Compounds and methods for treating spasticity. Provided herein are methods of treating and preven... |
|
|
Invention
|
Compounds and methods for treating spasticity.
Provided herein are methods of treating and preve... |
|
|
Invention
|
Methods and compounds useful in the synthesis of an aak1 inhibitor. Methods for the synthesis of ... |
|
|
Invention
|
Solid forms of (s)-1-((2',6-bis(difluoromethyl)-[2,4'-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-a... |
|
|
Invention
|
Solid forms of (s)-l-((2',6-bis(difluoromethyl)-[2,4'-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-a... |
|
|
Invention
|
Methods and compounds useful in the sythesis of an aak1 inhibitor. SS)-1-((2',6-bis(difluoromethy... |
|
|
Invention
|
Compositions comprising and methods of using inhibitors of sodium-glucose cotransporters 1 and 2.... |
|
2022
|
P/S
|
Pharmaceutical preparations for the treatment or prevention of heart failure |
|
|
Invention
|
Compounds and methods for treating or preventing cardiovascular diseases and conditions.
This in... |
|
|
Invention
|
Sotagliflozin for treating or preventing cardiovascular diseases. This invention relates to metho... |
|
|
Invention
|
Sotagliflozin for improving left atrial function.
This invention relates to sotagliflozin for us... |
|
2021
|
Invention
|
Pyrazolo[1,5]pyrimidine-based compounds and methods of their use to treat viral infections. Provi... |
|
|
Invention
|
Compounds and methods for treating viral infections. Provided herein are methods of treating, man... |
|
|
Invention
|
4-(3-(pyridin-3-yl)pyrazolo[1,5-a]pyrimidin-5-yl)piperazine for use in the the treatment of cov-2... |
|
|
Invention
|
Aak1 inhibitors for use in treating viral infections. Provided herein are adaptor associated kina... |
|
2020
|
Invention
|
Continuous process for preparing the crystalline form ii of sotagliflozin.
The present document ... |
|
|
Invention
|
Process for preparing the crystalline form ii of sotagliflozin.
The present document relates to ... |
|
|
Invention
|
Continuous process for preparing the crystalline form ii of sotagliflozin. The present document r... |
|
|
Invention
|
Process for preparing the crystalline form ii of sotagliflozin. The present document relates to a... |
|
|
Invention
|
Use of sotagliflozin for the treatment of patients with type 2 diabetes mellitus and moderate ren... |
|
|
Invention
|
Use of sotagliflozin for the treatment of patients with type 1 diabetes mellitus. The invention r... |
|
2019
|
Invention
|
Crystalline solid forms of n-(1-((2-(dimethylamino)ethyl)amino)-2-methyl-1-oxopropan-2-yl)-4-(4-(... |
|
|
Invention
|
Crystalline forms of n-(1-((2-(dimethylamino)ethyl)amino)-2-methyl-1-oopropan-2-yl)-4-(4-(2-methy... |
|
|
Invention
|
Crystalline forms of n-(1 -((2-(dimethylamino)ethyl)amino)-2-m ethyl-1 -oopropan-2-yl)-4-(4-(2-me... |
|
|
Invention
|
Antibodies that bind notum pectinacetylesterase. Antibodies that neutralize Notum Pectinacetylest... |
|
2018
|
Invention
|
Sodium glucose co-transporter inhibitors and methods of their use.
Sulfanyl-tetrahydropyran-base... |
|
|
P/S
|
Anti-diabetic preparation, excluding pharmaceutical preparations and substances for the treatment... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes. |
|
2017
|
P/S
|
Anti-diabetic preparations. |
|
|
Invention
|
Inhibitors of sodium glucose transporter 1 for constipation. Inhibitors of sodium glucose cotrans... |
|
2016
|
P/S
|
Business administration of patient reimbursement programs; medical billing support services; medi... |
|
|
Invention
|
Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use... |
|
2015
|
Invention
|
Antibodies that bind notum pectinacetylesterase.
Antibodies that neutralize Notum Pectinacetyles... |
|
|
Invention
|
Inhibitors of sodium glucose cotransporter 1. Inhibitors of sodium glucose cotransporter 1 (SGLT1... |
|
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of diabetes and cardiovascular disease; none of the... |
|
2007
|
P/S
|
Pharmaceutical preparations for the treatment of cancer, cardiovascular disease, diabetes, metabo... |
|
2002
|
P/S
|
Cardiovascular, anti-cancer, and anti-bacterial preparations and preparations for the treatment o... |
